Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates

Summary: SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still completely controlled, and therefore accessible second-generation vacc...

Full description

Bibliographic Details
Main Authors: Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, Mercè Roca, Luis González-González, Carme Garriga, Joachim Confais, Marion Toussenot, Hugues Contamin, Andrés Pizzorno, Manuel Rosa-Calatrava, Edwards Pradenas, Silvia Marfil, Julià Blanco, Paula Cebollada Rica, Marta Sisteré-Oró, Andreas Meyerhans, Cristina Lorca, Joaquim Segalés, Teresa Prat, Ricard March, Laura Ferrer
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:iScience
Subjects:
Health sciences
Immunology
Immune response
Microbiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223013019

Internet

http://www.sciencedirect.com/science/article/pii/S2589004223013019

Similar Items